OTCMKTS:CURLF Curaleaf (CURLF) Stock Price, News & Analysis $2.82 -0.04 (-1.40%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About Curaleaf Stock (OTCMKTS:CURLF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Curaleaf alerts:Sign Up Key Stats Today's Range$2.76▼$2.9950-Day Range$0.78▼$3.0752-Week Range$0.68▼$3.58Volume738,996 shsAverage Volume787,547 shsMarket Capitalization$1.89 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingStrong Buy Company Overview Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York. Read More Curaleaf Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks16th Percentile Overall ScoreCURLF MarketRank™: Curaleaf scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Curaleaf.Read more about Curaleaf's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Curaleaf are expected to grow in the coming year, from ($0.25) to ($0.18) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Curaleaf is -8.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Curaleaf is -8.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCuraleaf has a P/B Ratio of 2.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.76% of the float of Curaleaf has been sold short.Short Interest Ratio / Days to CoverCuraleaf has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Curaleaf has recently decreased by 0.74%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCuraleaf does not currently pay a dividend.Dividend GrowthCuraleaf does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.76% of the float of Curaleaf has been sold short.Short Interest Ratio / Days to CoverCuraleaf has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Curaleaf has recently decreased by 0.74%, indicating that investor sentiment is improving. News and Social Media2.4 / 5News Sentiment0.35 News SentimentCuraleaf has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Curaleaf this week, compared to 3 articles on an average week.Search InterestOnly 3 people have searched for CURLF on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.MarketBeat Follows7 people have added Curaleaf to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Curaleaf insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.03% of the stock of Curaleaf is held by institutions.Read more about Curaleaf's insider trading history. Receive CURLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter. Email Address CURLF Stock News HeadlinesWhy Curaleaf Stock Was Tumbling on TuesdayAugust 19 at 3:37 PM | fool.comThis Red-Hot Cannabis Stock Has Nearly Doubled in 2025. Should You Buy It Here?August 19 at 1:13 PM | finance.yahoo.comElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.August 22 at 2:00 AM | Paradigm Press (Ad)Curaleaf Is Still A Strong SellAugust 17, 2025 | seekingalpha.comSeaport Res Ptn Has Negative Outlook of Curaleaf Q3 EarningsAugust 15, 2025 | americanbankingnews.comCuraleaf, Canopy Growth miss Q3 marks while Ascend, Green Thumb ...August 14, 2025 | marketwatch.comWhy Curaleaf Stock Rocked the Market TodayAugust 13, 2025 | fool.comCuraleaf Q3 EPS Decreased by Alliance Global PartnersAugust 12, 2025 | americanbankingnews.comSee More Headlines CURLF Stock Analysis - Frequently Asked Questions How have CURLF shares performed this year? Curaleaf's stock was trading at $1.56 at the beginning of 2025. Since then, CURLF stock has increased by 80.1% and is now trading at $2.81. How were Curaleaf's earnings last quarter? Curaleaf Holdings, Inc. (OTCMKTS:CURLF) issued its quarterly earnings results on Wednesday, August, 6th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative trailing twelve-month return on equity of 14.61% and a negative net margin of 18.08%. How do I buy shares of Curaleaf? Shares of CURLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/06/2025Today8/22/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CURLF CIK1756770 Webwww.curaleaf.com Phone781-451-0351FaxN/AEmployees5,519Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$215.42 million Net Margins-18.08% Pretax Margin-9.81% Return on Equity-14.61% Return on Assets-4.47% Debt Debt-to-Equity Ratio1.00 Current Ratio1.47 Quick Ratio0.70 Sales & Book Value Annual Sales$1.34 billion Price / Sales1.42 Cash Flow$0.22 per share Price / Cash Flow12.84 Book Value$1.30 per share Price / Book2.19Miscellaneous Outstanding Shares670,460,000Free FloatN/AMarket Cap$1.91 billion OptionableNot Optionable Beta0.69 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:CURLF) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curaleaf Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Curaleaf With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.